Dimer Health vs Verily

Last VerifiedAugust 4, 2026
Verdict

Two clinical programmes wrapped in software, sold to different buyers for different windows. Dimer runs clinician led transitional care in the days after discharge, which is when readmission risk peaks and support is thinnest, and it is a bounded episode with a measurable endpoint. Verily runs chronic condition management and research programmes for plans, employers and pharmacy benefit managers, with a credible certification set and a better designed privacy structure than most consumer facing arrangements here. If your exposure is readmission penalties, Dimer is aimed at that specific window. If it is a chronic population managed across years, Verily is built for the longer horizon. Neither publishes engagement adjusted outcomes, which is what would show either programme worked rather than selected.

Select Dimer Health if
  • Clinician led transitional care concentrates on the days after discharge, when readmission risk is highest and support is thinnest.
  • A bounded episode with a measurable endpoint makes the programme's effect easier to attribute than ongoing monitoring.
  • For an organisation whose exposure is readmission penalties, the intervention window is the one that matters.
Select Verily if
  • It runs chronic condition management and research programmes for plans, employers and pharmacy benefit managers with a credible certification set.
  • The health privacy structure is better designed than most consumer facing arrangements in this index.
  • Agents triage and escalate members to a clinical team, with commitments published in language a member can read.
Attribute Matrix

Side by Side

Axis
D
Dimer Health
V
Verily
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Remote Monitoring & Chronic Care page.

Disclosure

The buyers differ, one selling to health systems carrying readmission exposure and the other to plans, employers and pharmacy benefit managers, so a like for like cost comparison does not exist. Neither publishes engagement adjusted outcomes, which is the figure that separates a programme that worked from one that recruited the already motivated. Verily names its products and agents but not the technology beneath them and publishes no governance framework. Dimer publishes little on security or retention.

AI Health Index

An independent reference for evaluating AI vendors in healthcare. No vendor pays for inclusion, placement, or rating.

Index Status
Last index update
August 4, 2026
The AI Health Index is an editorial reference, not a regulatory body. Vendor data is verified against published sources and public regulatory filings. Figures labeled “Estimated” have not been confirmed by the vendor. See the Methodology page for evaluation standards and limitations.
© 2026 AI Health Index
3801 N Capital of Texas Hwy, Ste E240 · Austin, TX 78746